Holmlin R. Erik 4
4 · Bionano Genomics, Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Holmlin R. Erik
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-15+1,400,000→ 1,400,000 totalExercise: $2.18Exp: 2032-02-14→ Common Stock (1,400,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.